Literature DB >> 29201241

Clinical value of urinary retinol-binding protein in ascites due to cirrhosis.

Yujing Xia1, Jingjing Li1, Sainan Li1, Tong Liu1, Yuqing Zhou1,2, Qin Yin1,2, Jianrong Wang1,3, Wenxia Lu1,3, Rong Zhang1,3, Yuanyuan Zheng1, Fan Wang1, Jie Lu1, Kan Chen1, Weiqi Dai1, Yingqun Zhou1, Chuanyong Guo1.   

Abstract

The aim of the present study was to explore the clinical value of urinary retinol-binding protein (RBP) level in the prognosis of cirrhotic ascites by assessment of the RBP levels prior to and following ascites treatment. The levels of urinary RBP, urinary microalbumin (mAlb), serum urea nitrogen (urea) and serum creatinine (Cr), and the estimated glomerular filtration rate (eGFR) were measured in 90 patients with cirrhosis and ascites hospitalized in a single institution between May 2011 and January 2012, and in 30 healthy controls. The levels of urinary mAlb, serum urea and serum Cr were higher in the cirrhotic patients compared with the healthy controls (P<0.05). Urinary RBP levels were significantly higher and eGFR was significantly lower in the liver cirrhosis group compared with the healthy control group (P<0.01). Urinary RBP, urinary mAlb, serum urea and serum Cr increased and eGFR decreased as the severity of the ascites increased (P<0.05). Urinary RBP was significantly higher in patients whose ascites did not respond or was refractory compared with those in whom it subsided (P<0.05), exhibiting a gradual increase over time in the former and a gradual reduction over time in the latter group (P<0.05). Increased urinary RBP and decreased eGFR in the early stage of cirrhosis ascites suggested impaired renal function, which serves a role in the process of ascites formation. These results indicated that urinary RBP is a sensitive indicator of early renal injury in patients with ascites due to cirrhosis and is closely associated with the progression of cirrhotic ascites.

Entities:  

Keywords:  ascites; cirrhosis; urinary retinol-binding protein

Year:  2017        PMID: 29201241      PMCID: PMC5704310          DOI: 10.3892/etm.2017.5190

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  Management of ascites in cirrhosis.

Authors:  Bimaljit Singh Sandhu; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2005-11       Impact factor: 6.126

3.  microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway.

Authors:  Zhenyu Liu; Jingjie Wang; Chuanyong Guo; Xiaoming Fan
Journal:  Biomed Pharmacother       Date:  2014-11-06       Impact factor: 6.529

Review 4.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

5.  Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country.

Authors:  Choon-Seng Qua; Khean-Lee Goh
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

6.  Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis.

Authors:  M Levy; M J Wexler
Journal:  Am J Physiol       Date:  1987-10

7.  Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein.

Authors:  H L Monaco; M Rizzi; A Coda
Journal:  Science       Date:  1995-05-19       Impact factor: 47.728

Review 8.  Pathophysiology and management of pediatric ascites.

Authors:  Mahmoud Sabri; Miguel Saps; John M Peters
Journal:  Curr Gastroenterol Rep       Date:  2003-06

9.  Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy.

Authors:  Yuqing Zhou; Qian Dong; Rong Zhang; Shunfeng Zhou; Linqiang Li; Keran Cheng; Rui Kong; Qiang Yu; Shizan Xu; Jingjing Li; Sainan Li; Jiao Feng; Liwei Wu; Tong Liu; Xiya Lu; Kan Chen; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2016-12-21       Impact factor: 2.260

10.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.